Patents by Inventor Anna Kazantseva

Anna Kazantseva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
    Patent number: 8664359
    Abstract: The invention is related to isoforms of components of transcription factor complexes that are specifically expressed in cancer cells. These isoforms can be used as biomarkers for detection, diagnosis, prognosis and monitoring of treatments of cancer, and as drug targets of pharmaceutical compositions for the treatment of various cancers expressing the targeted isoforms. Methods, molecules, materials and kits for these uses are disclosed.
    Type: Grant
    Filed: June 3, 2008
    Date of Patent: March 4, 2014
    Assignee: OncoTx, Inc.
    Inventors: Anna Kazantseva, Jekaterina Kazantseva
  • Compositions and methods for targeting cancer-specific transcription complexes
    Patent number: 7973135
    Abstract: The invention provides molecules that target cancer-specific transcription complexes (CSTC), compositions and kits comprising CSTC-targeting molecules, and methods of using CSTC-targeting molecules for the treatment) detection and monitoring of cancer.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: July 5, 2011
    Assignee: Oncotx, Inc.
    Inventors: Anzelika Liik, Anna Kazantseva
  • TRANSCRIPTIONAL BIOMARKERS AND METHODS FOR DETECTING AND ISOLATING CANCER CELLS IN BODY FLUIDS AND TISSUE SPECIMENS
    Publication number: 20110151478
    Abstract: The invention provides molecules that target cancer-specific transcription complexes (CSTC), compositions and kits comprising CSTC-targeting molecules, and methods of using CSTC-targeting molecules for the treatment, detection and monitoring of cancer.
    Type: Application
    Filed: February 23, 2011
    Publication date: June 23, 2011
    Applicant: Oncotx, Inc.
    Inventors: ANZELIKA LIIK, Anna Kazantseva
  • CANCER RELATED ISOFORMS OF COMPONENTS OF TRANSCRIPTION FACTOR COMPLEXES AS BIOMARKERS AND DRUG TARGETS
    Publication number: 20100087376
    Abstract: The invention is related to isoforms of components of transcription factor complexes that are specifically expressed in cancer cells. These isoforms can be used as biomarkers for detection, diagnosis, prognosis and monitoring of treatments of cancer, and as drug targets of pharmaceutical compositions for the treatment of various cancers expressing the targeted isoforms. Methods, molecules, materials and kits for these uses are disclosed.
    Type: Application
    Filed: June 3, 2008
    Publication date: April 8, 2010
    Applicant: Oncotx, Inc.
    Inventors: Anna Kazantseva, Jekaterina Kazantseva
  • COMPOSITIONS AND METHODS FOR TARGETING CANCER-SPECIFIC TRANSCRIPTION COMPLEXES
    Publication number: 20080027002
    Abstract: The invention provides molecules that target cancer-specific transcription complexes (CSTC), compositions and kits comprising CSTC-targeting molecules, and methods of using CSTC-targeting molecules for the treatment) detection and monitoring of cancer.
    Type: Application
    Filed: July 12, 2007
    Publication date: January 31, 2008
    Applicant: Oncotx, Inc.
    Inventors: Anzelika Liik, Anna Kazantseva